DNA Sensing and Neuroinflammation: Mechanistic Insights into cGAS-STING Biology and Therapeutic Translation in Age-Related Neurodegenerative Diseases.
DNA-sensing immune signaling in the brain fuels neuroinflammation in Alzheimer's, pointing to druggable targets being developed in multiple programs.
This Molecular Neurobiology review frames cGAS-STING signaling as a central upstream mediator of neuroinflammation in age-related neurodegeneration, linking genomic instability and mitochondrial dysfunction to sustained innate immune activation in the brain. The review highlights current pharmacological cGAS-STING inhibitor development and genetic modulation evidence supporting the pathway as a druggable target for Alzheimer's and other neurodegenerative diseases.
What the study was
- Study design
- narrative_review
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Mol Neurobiol
Why it surfaced
cGAS-STING is a rapidly maturing therapeutic target with multiple clinical candidates; its connection to aging, neuroinflammation, and AD makes it directly relevant to the aging/longevity watchlist; several inhibitors are now in phase I/II trials making this review timely.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.